Physician profile
David B Rice
NPI 1740232248
$4,070.81
in general payments reported to CMS, 2019-2025
22 companies · $611 in 2025
The $611 reported for 2025 was less than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $70.67 · 2022: $581 · 2023: $1,432 · 2024: $1,376 · 2025: $611.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $2,367 · Food and Beverage: $1,052.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $2,366.90 |
| Food and Beverage | $1,052.21 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Procept Biorobotics Corporation | $2,071.16 | 2023-2024 | Aquabeam Robotic System, Aquabeam System |
| Intuitive Surgical, INC. | $571.13 | 2025 | |
| Medtronic, INC. | $205.69 | 2022 | |
| Sumitomo Pharma America, INC. | $202.83 | 2023-2025 | Gemtesa, Orgovyx |
| Urogen Pharma, INC. | $131.04 | 2021-2024 | Jelmyto |
| Accord Healthcare, INC. | $124.10 | 2023-2024 | |
| Myriad Genetic Laboratories, INC. | $97.20 | 2022-2024 | Prolaris |
| Ambu INC. | $93.34 | 2022-2025 | |
| 180 Medical, INC. | $93.20 | 2021-2024 | |
| Janssen Biotech, INC. | $85.05 | 2022 | |
| Merck Sharp & Dohme LLC | $71.00 | 2022-2023 | Welireg, Lynparza, Keytruda |
| Boston Scientific Corporation | $54.36 | 2022 | |
| Immunitybio, INC. | $49.99 | 2024 | |
| Sun Pharmaceutical Industries INC. | $46.58 | 2022-2023 | Yonsa, Odomzo |
| Myovant Sciences INC. | $34.94 | 2021-2022 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tolmar Pharmaceuticals, INC. | $29.02 | 2021-2022 | |
| Tolmar, INC. | $23.54 | 2023 | |
| Laborie Medical Technologies Corp. | $22.78 | 2023 | |
| Bayer Healthcare Pharmaceuticals INC. | $17.00 | 2023 | |
| Olympus America INC. | $16.88 | 2022 | |
| Urovant Sciences INC | $16.48 | 2022 | |
| Endo Pharmaceuticals INC. | $13.50 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Rice listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.